A multicentric, prospective and randomized therapy optimization trial on adjuvant chemotherapy of high-risk node-negative breast cancer patients as identified by tumour biological factos (uPA/PAI-1, HER-2/neu, TK/TS): six courses FEC vs three courses
Projektleiter:
Finanzierung:
Fördergeber - Sonstige;
A multicentric, prospective and randomized therapy optimization trial on adjuvant chemotherapy of high-risk node-negative breast cancer patients as identified by tumour biological factors (uPA/PAI-1, HER-2/neu, TK/TS): six courses FEC vs three courses FEC followed by three courses Docetaxel
Kontakt
Prof. Dr. habil. Christoph Thomssen
Martin-Luther-Universität Halle-Wittenberg
Universitätsklinik und Poliklinik für Gynäkologie
Ernst-Grube-Str. 40
06120
Halle (Saale)
Tel.:+49 345 5571847
weitere Projekte
Die Daten werden geladen ...